These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9090353)

  • 1. Efficacy of papaverine addition for treatment-refractory major depression.
    Malison RT; Price LH; Nestler EJ; Heninger GR; Duman RS
    Am J Psychiatry; 1997 Apr; 154(4):579-80. PubMed ID: 9090353
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination treatment with venlafaxine and bupropion.
    Kirsch MA; Louie AK
    Am J Psychiatry; 1999 Mar; 156(3):494. PubMed ID: 10080572
    [No Abstract]   [Full Text] [Related]  

  • 3. Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report.
    Bader GM; Hawley JM; Short DD
    J Clin Psychopharmacol; 1998 Jun; 18(3):255-6. PubMed ID: 9617988
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases.
    Gonul AS; Akdeniz F; Donat O; Vahip S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):889-91. PubMed ID: 12921926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression.
    Fischer P; Tauscher J; Küfferle B; Kasper S
    Int Clin Psychopharmacol; 1998 Mar; 13(2):83-6. PubMed ID: 9669189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression.
    Joffe RT; Schuller DR
    J Clin Psychiatry; 1993 Jul; 54(7):269-71. PubMed ID: 8335654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine versus sertraline for major depressive disorder.
    Wise TN; Sheridan MJ
    J Clin Psychiatry; 2000 Nov; 61(11):873-4. PubMed ID: 11105744
    [No Abstract]   [Full Text] [Related]  

  • 8. [Venlafaxine (velaxin) effectivity in treatment of depression: results of the recent investigations].
    Veltishchev DY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11 Pt 2):79-81. PubMed ID: 24429970
    [No Abstract]   [Full Text] [Related]  

  • 9. Lithium augmentation in venlafaxine-refractory depression.
    Zullino D; Preisig M; Baumann P
    J Clin Psychopharmacol; 2001 Apr; 21(2):242-3. PubMed ID: 11270926
    [No Abstract]   [Full Text] [Related]  

  • 10. Venlafaxine withdrawal reactions.
    Louie AK; Lannon RA; Kirsch MA; Lewis TB
    Am J Psychiatry; 1996 Dec; 153(12):1652. PubMed ID: 8942467
    [No Abstract]   [Full Text] [Related]  

  • 11. Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety.
    Judge R; Wagner BE
    J Clin Psychiatry; 1999 Nov; 60(11):795-6. PubMed ID: 10584775
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
    Nelson JC
    Depress Anxiety; 1998; 7 Suppl 1():5-6. PubMed ID: 9597344
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug therapy in treatment-resistant depression.
    Malhi GS; Farmer AE
    Br J Psychiatry; 1999 Oct; 175():390-1. PubMed ID: 10789311
    [No Abstract]   [Full Text] [Related]  

  • 14. Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
    Gaynes BN; Farley JF; Dusetzina SB; Ellis AR; Hansen RA; Miller WC; Stürmer T
    Depress Anxiety; 2011 Nov; 28(11):989-98. PubMed ID: 21898717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming treatment resistance in depression.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 16():13-9; discussion 40-2. PubMed ID: 9796861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine-induced hair loss.
    Pitchot W; Ansseau M
    Am J Psychiatry; 2001 Jul; 158(7):1159-60. PubMed ID: 11431245
    [No Abstract]   [Full Text] [Related]  

  • 17. Venlafaxine XR and chronic pelvic pain syndrome.
    Karp JF
    J Clin Psychiatry; 2004 Jun; 65(6):880-1. PubMed ID: 15291672
    [No Abstract]   [Full Text] [Related]  

  • 18. Venlafaxine versus fluoxetine.
    Paton C
    J Clin Psychiatry; 1999 Oct; 60(10):708. PubMed ID: 10549691
    [No Abstract]   [Full Text] [Related]  

  • 19. Venlafaxine-associated hypomania in unipolar depression.
    Chand PK; Kalyani GS; Murthy P
    Can J Psychiatry; 2004 Jul; 49(7):496. PubMed ID: 15362257
    [No Abstract]   [Full Text] [Related]  

  • 20. Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression.
    Bouwer C; Stein DJ
    S Afr Med J; 1997 Apr; 87(4 Suppl):534-7, 540. PubMed ID: 9180827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.